The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study
Open accessAbstract
Objectives To determine any long-term effects, 6 and 8 years after childhood enrollment, of the randomly assigned 14-month treatments in the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA; N = 436); to test whether attention-deficit/hyperactivity disorder (ADHD) symptom trajectory through 3 years predicts outcome in subsequent years; and to examine functioning level of the MTA adolescents relative to their non-ADHD peers (local normative comparison group; N = 261).Method Mixed-effects regression models with planned contrasts at 6 and 8 years tested a wide range of symptom and impairment variables assessed by parent, teacher, and youth report.Results In nearly every analysis, the originally randomized treatment groups did not differ significantly on repeated measures or newly analyzed variables (e.g., grades earned in school, arrests, psychiatric hospitalizations, other clinically relevant outcomes). Medication use decreased by 62% after the 14-month controlled trial, but adjusting for this did not change the results. ADHD symptom trajectory in the first 3 years predicted 55% of the outcomes. The MTA participants fared worse than the local normative comparison group on 91% of the variables tested.Conclusions Type or intensity of 14 months of treatment for ADHD in childhood (at age 7.0-9.9 years) does not predict functioning 6 to 8 years later. Rather, early ADHD symptom trajectory regardless of treatment type is prognostic. This finding implies that children with behavioral and sociodemographic advantage, with the best response to any treatment, will have the best long-term prognosis. As a group, however, despite initial symptom improvement during treatment that is largely maintained after treatment, children with combined-type ADHD exhibit significant impairment in adolescence. Innovative treatment approaches targeting specific areas of adolescent impairment are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Long-term follow-up studies suggest that hyperactive and impulsive behaviors tend to decrease with age, while inattentive symptoms show greater persistence and may stay life-long (Biederman et al., 2000; Molina et al., 2009).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“potential longer-term efficacy could be the real advantage of tDCS over stimulant medication where effects are discontinued with discontinued drug administration and where effects appear to even wane in long-term continuous administration (Molina et al., 2009), presumably due to brain adaptation to the drug (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such delayed consolidation effects reinforce the notion that brain self-regulation via NF affects neuroplasticity and may hence have unique longer-term efficacy compared to stimulant medication which does not affect neuroplasticity and may even loose efficacy over time (Molina et al., 2009), due to potential brain adaptation (Fusar-Poli et al., 2012).”
From Cognitive Neuroscience of Attention Deficit Hyperactivity Disorder (ADHD) and Its Clinical Translation (2018) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite this large difference in medication use, there were no appreciable between-group differences in long-term academic achievement in reading or mathematics (Molina et al., 2009).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is the first study of its kind, and results are consistent with other randomized evidence with less controlled designs (Molina et al., 2009; Tamm et al., 2017) in failing to support the expectation that taking stimulant medication during childhood will impact children with ADHD’s long-term academic achievement.”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have identified childhood risk factors associated with a more persistent course, including higher levels of symptoms, comorbid oppositional-defiant disorder (ODD), lower IQ, and family socioeconomic disadvantage.”
From Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood (2016) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
From Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“We are aware of only two such studies (Molina et al., 2009; Tamm et al., 2017).”
From The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) · cites this paper as Molina et al., 2009
In the citing paper
“data suggest limited longer-term benefits of stimulant and behavioral interventions, even when applied intensively for both school-age and preschool children (Molina et al., 2009; Riddle et al., 2013).”
From Improving Outcomes for Youth with ADHD: A Conceptual Framework for Combined Neurocognitive and Skill-Based Treatment Approaches (2014) · cites this paper as Molina et al., 2009
In the citing paper
“This suggests that the relative benefits of childhood treatment with stimulant medication, compared with non-pharmacological treatmentsFimprovement in cognitive deficits as well as reductions in symptom severityFmay dissipate after a 2-to 3-year period, whether or not the medication component of treatment is continued or withdrawn (Molina et al, 2009;Swanson et al, 2008a, b).”
From Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) · cites this paper as Molina et al, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Roberts, B. W., & DelVecchio, W. F. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.1.3 · Cited by 3,241
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,592
Cited by
Sorted by citations
Items 501–600 of 1,000
Transitional care to adult ADHD services in a North West England district
Ogundele, M. O. (2013) · Clinical Governance An International Journal · doi:10.1108/cgij-01-2013-0001 · Cited by 21
O’Neill, S. C., Rajendran, K., & Halperin, J. M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.106 · Cited by 20
Boyer, B. E., Doove, L. L., Geurts, H. M., Prins, P. J. M., Mechelen, I. V., & der Oord, S. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150698 · Cited by 24
Aikins, R. D., Zhang, X., & McCabe, S. E. (2017) · Journal of Academic Ethics · doi:10.1007/s10805-017-9291-0 · Cited by 20
Nichols, J. Q., Shoulberg, E. K., Garner, A. A., Hoza, B., Burt, K. B., Murray-Close, D. K., & Arnold, L. E. (2016) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-016-0183-3 · Cited by 20
Self-citationMeinzer, M. C., Hartley, C. M., Hoogesteyn, K., & Pettit, J. W. (2017) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2017.05.006 · Cited by 20
Nigg, J. (2018) · JAMA pediatrics · doi:10.1001/jamapediatrics.2018.0920 · Cited by 18
DuPaul, G. J., Kern, L., Caskie, G. I. L., & Volpe, R. J. (2015) · School Psychology Review · doi:10.17105/spr44-1.3-20 · Cited by 18
Pelham, W. E., Altszuler, A. R., Merrill, B. M., Raiker, J. S., Macphee, F. L., Ramos, M., Gnagy, E. M., Greiner, A. R., Coles, E. K., Connor, C. M., et al. (2022) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000725 · Cited by 19
“This is the first study of its kind, and results are consistent with other randomized evidence with less controlled designs (Molina et al., 2009; Tamm et al., 2017) in failing to support the expectation that taking stimulant medication during childhood will impact children with ADHD’s long-term…”
BackgroundResultInfluentialSelf-citationADHD Medication in the Longer Term
Taylor, E. A. (2019) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000664 · Cited by 24
The Potential Role of Dopamine in Mediating Motor Function and Interpersonal Synchrony
Gvirts, H. Z., & Dahan, A. (2021) · Biomedicines · doi:10.3390/biomedicines9040382 · Cited by 22
Burcu, M., Manzano-Salgado, C. B., Butler, A. M., & Christian, J. B. (2021) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-021-00322-8 · Cited by 19
Stevenson, M. P., McEwan, J., Bentsen, P., Schilhab, T. S. S., Glue, P., Trani, P., Wheeler, B. J., & Healey, D. M. (2021) · Journal of Environmental Psychology · doi:10.1016/j.jenvp.2021.101679 · Cited by 22
Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder
Bukstein, O. G., & Head, J. C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.721778 · Cited by 21
Ganesh, S., Kandasamy, A., Sahayaraj, U. S., & Benegal, V. (2017) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.198945 · Cited by 19
Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database
Vitiello, B., Algorta, G. P., Arnold, L. E., Howard, A. L., Stehli, A., & Molina, B. S. G. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.01.016 · Cited by 20
Self-citationWaxmonsky, J. G., Baweja, R. K., Liu, G., Waschbusch, D. A., Fogel, B. N., LESLIE, D. L., & Pelham, W. E. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800473 · Cited by 19
Chronic Disorders in Children and Adolescents
Goldstein, M. L., & Morewitz, S. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9764-7 · Cited by 19
Predicting poor school performance in children suspected for sleep-disordered breathing
BROCKMANN, P. E., V, Schlaud, M., Poets, C. F., & Urschitz, M. S. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.03.021 · Cited by 19
Executive Function/Cognitive Training for Children with ADHD: Do Results Warrant the Hype and Cost?
Orban, S. A., Rapport, M. D., Friedman, L. M., & Kofler, M. J. (2014) · The ADHD Report · doi:10.1521/adhd.2014.22.8.8 · Cited by 22
Raiker, J. S., Friedman, L. M., Orban, S. A., Kofler, M. J., Sarver, D. E., & Rapport, M. D. (2017) · Journal of Attention Disorders · doi:10.1177/1087054716686182 · Cited by 21
Adolescence as a turning point: for better and worse
Buitelaar, J. K. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0296-3 · Cited by 19
Stobernack, T., de Vries, S. P. W., Pereira, R. R., Pelsser, L. M. J., ter Braak, C. J. F., Aarts, E., van Baarlen, P., Kleerebezem, M., Frankena, K., & Hontelez, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029422 · Cited by 17
Dvorsky, M. R., Friedman, L. M., Spiess, M. I., & Pfiffner, L. J. (2020) · Behavior Therapy · doi:10.1016/j.beth.2020.09.007 · Cited by 18
Strategies for improving ADHD medication adherence.
Kamimura-Nishimura, K. I., Brinkman, W. B., & Froehlich, T. E. (2019) · PubMed · Cited by 18
Durá-Travé, T., & Gallinas-Victoriano, F. (2014) · JRSM Open · doi:10.1177/2042533313517690 · Cited by 18
Margari, L., Margari, F., Craig, F., Tegola, D. L., Matera, E., Lamanna, A. L., Carabellese, F., & Lecce, P. A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75942 · Cited by 18
Psychodynamic psychotherapy of ADHD: A review of the literature.
Conway, F. P. (2012) · Psychotherapy · doi:10.1037/a0027344 · Cited by 18
Quansah, E., Ruiz‐Rodado, V., Grootveld, M. C., Probert, F., & Zetterström, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.003 · Cited by 18
The Impact of DSM-5 A-Criteria Changes on Parent Ratings of ADHD in Adolescents
Sibley, M. H., & Yegüez, C. E. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714526040 · Cited by 19
Kuriyan, A. B., Pelham, W. E., Molina, B. S. G., Waschbusch, D. A., Sibley, M. H., & Gnagy, E. M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0081 · Cited by 18
Self-citationHammond, D. C. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.570694 · Cited by 19
Kim, J. W., Kim, B.-N., Kim, J. I., Lee, Y. S., Min, K. J., Kim, H.-J., & Lee, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142782 · Cited by 18
Attention-Deficit/Hyperactivity Disorder (ADHD) in Children
Waschbusch, D. A., & King, S. (2014) · Oxford University Press eBooks · doi:10.1093/obo/9780199828340-0152 · Cited by 18
Utilizing Student Health and Academic Data: A County-Level Demonstration Project
Carter‐Pokras, O., Bugbee, B. A., Gold, R. S., Lauver, P. E., Aiken, R., & Arria, A. M. (2019) · Health Promotion Practice · doi:10.1177/1524839919862796 · Cited by 17
Sibley, M. H., Bickman, L., Coxe, S. J., Graziano, P. A., & Martin, P. (2020) · Behavior Therapy · doi:10.1016/j.beth.2020.10.007 · Cited by 17
Hong, M., Lee, W. H., Moon, D. S., Lee, S. M., Chung, U., & Bahn, G. H. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0090 · Cited by 16
Relationship of Dropout and Psychopathology in a High School Sample in Mexico
Chalita, P. J., Palacios, L., Cortes, J. F., Landeros‐Weisenberger, A., Panza, K. E., & Bloch, M. H. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00020 · Cited by 16
Mirza, H., Roberts, E., Al-Belushi, M. A. K., AL-Salti, H., Al-Hosni, A., Jeyaseelan, L., & Al‐Adawi, S. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000522 · Cited by 17
One-year follow-up of two novel CBTs for adolescents with ADHD
Boyer, B. E., Geurts, H. M., Prins, P. J. M., & der Oord, S. V. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0776-3 · Cited by 17
Early Developmental Cues for Diagnosis of Attention Deficit/Hyperactivity Disorder in Young Children
Berger, I., & Nevo, Y. (2011) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1111 · Cited by 19
Arnold, L. E., Ober, N., Aman, M. G., Handen, B. L., Smith, T. H., Pan, X. J., Hyman, S. L., Hollway, J. A., Lecavalier, L., Buchan-Page, K. A., et al. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0134 · Cited by 17
Self-citationClinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
Jensen, P. S. (2009) · PubMed · Cited by 17
Self-citationRoy, A., Garner, A. A., Epstein, J. N., Hoza, B., Nichols, J. Q., Molina, B. S. G., Swanson, J. M., Arnold, L. E., & Hechtman, L. T. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.08.007 · Cited by 17
Self-citationArnold, L. E., Meter, A. V., Fristad, M. A., Youngstrom, E. A., Birmaher, B. B., Findling, R. L., Horwitz, S. M., & Black, S. R. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13122 · Cited by 48
Self-citationHai, T., Duffy, H. A., Lemay, J. A., & Lemay, J. F. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i1.48 · Cited by 16
Beyond DSM: The Role of Auditory Processing in Attention and Its Disorders
Bailey, T. (2012) · Applied Neuropsychology Child · doi:10.1080/21622965.2012.703890 · Cited by 16
Using task performance to inform treatment planning for youth with ADHD: A systematic review
Molitor, S. J., & Langberg, J. M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.007 · Cited by 17
Döpfner, M., Mandler, J., Breuer, D., Schürmann, S., Dose, C., Walter, D., & von Wirth, E. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720948133 · Cited by 18
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 23
Feasibility of School-Based ADHD Interventions
Bussing, R., Koro‐Ljungberg, M., Gagnon, J. C., Mason, D. M., Ellison, A. T., Noguchi, K., GARVAN, C. W., & Albarracín, D. (2014) · Journal of Attention Disorders · doi:10.1177/1087054713515747 · Cited by 16
Sokhadze, E. M., Stewart, C., Tasman, A., Daniels, R., & Trudeau, D. L. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.595298 · Cited by 16
Ibrahim, K., Vogt, C., & Donyai, P. (2016) · Child and Adolescent Mental Health · doi:10.1111/camh.12156 · Cited by 22
What we do not know about ADHD… yet
Kiely, B. T., & ADESMAN, A. R. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000229 · Cited by 16
Expert Recommendations for Improving Driving Safety for Teens and Adult Drivers with ADHD
Aduen, P. A., Cox, D. J., Fabiano, G. A., Garner, A. A., & Kofler, M. J. (2019) · The ADHD Report · doi:10.1521/adhd.2019.27.4.8 · Cited by 18
Bolfer, C. P. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-24022015-115036 · Cited by 16
Psychopharmacological Treatment of ADHD in Adults Aged 50+: An Empirical Study
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2015) · Journal of Attention Disorders · doi:10.1177/1087054714527342 · Cited by 18
Psychiatry Under the Influence
Whitaker, R. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-44911-1_7 · Cited by 15
Kanevski, M., Booth, J. N., Oldridge, J., McDougal, E., Stewart, T. M., McGeown, S. P., & Rhodes, S. (2021) · Child Neuropsychology · doi:10.1080/09297049.2021.1985444 · Cited by 17
Premarket Safety and Efficacy Studies for ADHD Medications in Children
Bourgeois, F. T., Kim, J., & Mandl, K. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102249 · Cited by 17
Accessible online neuroplasticity-targeted training for children with ADHD
Mishra, J., Merzenich, M. M., & Sagar, R. (2013) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-7-38 · Cited by 15
McDermott, A. F., Rose, M. C., Norris, T. W., & Gordon, E. (2016) · Journal of Attention Disorders · doi:10.1177/1087054715623044 · Cited by 21
Schrantee, A., Bouziane, C., Bron, E. E., Klein, S., Bottelier, M. A., Kooij, J. J. S., Rombouts, S. A. R. B., & Reneman, L. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9707-x · Cited by 16
Safer, D. J., & ZITO, J. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00705 · Cited by 17
Lewis, T. J. (2016) · Journal of Emotional and Behavioral Disorders · doi:10.1177/1063426616652866 · Cited by 15
Lange, K. W. (2017) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/mnhd.4 · Cited by 15
de Farias, A. C., Cordeiro, M. L., Felden, É. P. G., Bara, T. D. S., Benko, C. R., Coutinho, D., Martins, L. F., Chimaleski, R. T., & McCracken, J. T. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s136663 · Cited by 19
Swanson, J. M., Wigal, T. L., Jensen, P. S., Mitchell, J. T., Weisner, T. S., Murray, D. W., Arnold, L. E., Hechtman, L. T., Molina, B. S. G., Owens, E. B., et al. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717714058 · Cited by 16
Self-citationWalker, H. M., Forness, S. R., & Lane, K. L. (2014) · Emerald Group Publishing Limited eBooks · doi:10.1108/s0735-004x20140000027009 · Cited by 16
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
Hammerness, P., Fried, R., Petty, C., Meller, B., & Biederman, J. (2014) · Child Neuropsychology · doi:10.1080/09297049.2013.790359 · Cited by 14
Weiss, M. D., Cutler, A. J., Kollins, S. H., & Donnelly, G. A. E. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0034 · Cited by 14
Motorsports Involvement Among Adolescents and Young Adults with Childhood ADHD
Wymbs, B. T., Molina, B. S. G., Belendiuk, K. A., Pedersen, S. L., Walther, C. A. P., Cheong, J., McGinley, J. S., Marshal, M. P., Gnagy, E. M., & Pelham, W. E. (2013) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2012.759227 · Cited by 15
Self-citationKubas, H. A., Backenson, E. M., Wilcox, G., Piercy, J. C., & Hale, J. B. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2592 · Cited by 14
Courtabessis, É., Pupier, F., Sürig, L., Picot, M., Nogué, E., Macioce, V., Stein, E. M., & Purper‐Ouakil, D. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1061-4 · Cited by 14
Sibley, M. H., & Coxe, S. J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02734-6 · Cited by 14
Psychosocial Interventions for College Students with ADHD: Current Status and Future Directions
Vasko, J. M., Oddo, L. E., Meinzer, M. C., Garner, A. M., & Chronis-Tuscano, A. M. (2020) · The ADHD Report · doi:10.1521/adhd.2020.28.4.5 · Cited by 15
Four-Year Follow-Up of High versus Low Intensity Summer Treatment for Adolescents with ADHD
Sibley, M. H., Coxe, S. J., Page, T. F., Pelham, W. E., Yegüez, C. E., LaCount, P. A., & Barney, S. (2020) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2020.1833734 · Cited by 14
Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD
Pelham, W. E., Gnagy, E. M., Sibley, M. H., Kipp, H., Smith, B. H., Evans, S. W., & Bukstein, O. G. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713493320 · Cited by 14
Fleisher, C., & McGough, J. J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934806 · Cited by 14
Dopamine D3 Receptor Mediates Preadolescent Stress-Induced Adult Psychiatric Disorders
Seo, J. H., & Kuzhikandathil, E. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143908 · Cited by 14
Pilot Evaluation of the Medication Integration Protocol for Adolescents With ADHD in Behavioral Care
Hogue, A., Lichvar, E., & Bobek, M. (2015) · Journal of Emotional and Behavioral Disorders · doi:10.1177/1063426615611648 · Cited by 14
Hogue, A., Evans, S. W., & LEVIN, F. R. (2017) · Journal of Child & Adolescent Substance Abuse · doi:10.1080/1067828x.2017.1305930 · Cited by 16
Barnard-Brak, L., Roberts, B., & Valenzuela, E. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718763738 · Cited by 12
Nass, R. D., & Ross, G. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00086-4 · Cited by 14
Lorenzo, R. D., Balducci, J., Cutino, A., Latella, E., Venturi, G., Rovesti, S., Filippini, T., & Ferri, P. (2023) · Medicina · doi:10.3390/medicina59020338 · Cited by 14
A review of long-acting medications for ADHD in Canada.
Hosenbocus, S., & Chahal, R. (2009) · PubMed Central · Cited by 13
Tsai, C.-J., Chou, P., Cheng, C., Lin, C., Lan, T., & Lin, C. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600403 · Cited by 13
Program for the Education and Enrichment of Relational Skills: Parental Outcomes With an ADHD Sample
Gonring, K., Gerdes, A. C., & Gardner, D. (2017) · Child & Family Behavior Therapy · doi:10.1080/07317107.2016.1268003 · Cited by 13
Leaberry, K. D., Rosen, P. J., Slaughter, K. E., Reese, J. S., & Fogleman, N. D. (2019) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-019-00294-8 · Cited by 17
Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy
Panei, P., Arcieri, R., Bonati, M. R., Bugarini, M., Didoni, A., & Germinario, E. A. P. (2010) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0b013e3283383a63 · Cited by 13
Parent Cognitions and Behavioral Parent Training: Engagement and Outcomes
Kaiser, N. M., Hinshaw, S. P., & Pfiffner, L. J. (2010) · The ADHD Report · doi:10.1521/adhd.2010.18.1.6 · Cited by 13
Self-citationChildhood ADHD and treatment outcome: the role of maternal functioning
Rasmussen, P. D., Storebø, O. J., Shmueli‐Goetz, Y., Bojesen, A. B., Simonsen, E. H., & Bilenberg, N. (2018) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-018-0234-3 · Cited by 13
LaCount, P. A., Hartung, C. M., Canu, W. H., & Knouse, L. E. (2018) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2018.1518120 · Cited by 17
Shepard, E., Sweeney, C., Thompson, L., Jacobs, S., Grimm, J., & Weyandt, L. L. (2022) · Applied Neuropsychology Child · doi:10.1080/21622965.2022.2106436 · Cited by 12
ADHD and psychostimulants — overdiagnosis and overprescription
Dunlop, A. J., & Newman, L. K. (2016) · The Medical Journal of Australia · doi:10.5694/mja15.01387 · Cited by 12
Services for adults with ADHD: work in progress
Coghill, D. (2015) · BJPsych Bulletin · doi:10.1192/pb.bp.114.048850 · Cited by 12
Cultivating Compassion ADHD Project: A Mentalization Informed Psychodynamic Psychotherapy Approach
Conway, F. P., Lyon, S. J., Silber, M., & Donath, S. (2019) · Journal of Infant Child and Adolescent Psychotherapy · doi:10.1080/15289168.2019.1654271 · Cited by 12
Campez, M., Raiker, J. S., Sarver, D. E., Friedman, L. M., Orban, S. A., & Rapport, M. D. (2019) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-019-09762-x · Cited by 12
Executive function training for children with attention-deficit/hyperactivity disorder
Rapport, M. D., Eckrich, S. J., Calub, C. A., & Friedman, L. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815755-8.00008-3 · Cited by 12
Kolko, D. J., Hart, J., Campo, J. V., Sakolsky, D. J., Rounds, J. L., Wolraich, M. L., & Wisniewski, S. R. (2020) · Clinical Pediatrics · doi:10.1177/0009922820920013 · Cited by 12
Metadata
- Authors
- Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R.
- Affiliations
- University of Pittsburgh (US)
- University of California, Berkeley (US)
- University of California, Irvine (US)
- National Institute of Mental Health (US)
- Duke University (US)
- Long Island Jewish Medical Center (US)
- New York State Psychiatric Institute (US)
- University of Illinois Chicago (US)
- Corresponding author
- Molina, Brooke S.G.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 48
- Issue
- 5
- Pages
- 484-500
- ISSN
- 0890-8567 (ISSN-L)
- PMC
- PMC3063150
- OpenAlex
- W2144385879
- Cited by
- 1,182
- References
- 55
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 37 · 2023: 39 · 2022: 53 · 2021: 44 · 2020: 69 · 2019: 79 · 2018: 59 · 2017: 85 · 2016: 108 · 2015: 92 · 2014: 109 · 2013: 76 · 2012: 94
- FWCI
- 53.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- U.S. Department of Justice
- U.S. Department of Education
- Abbott Laboratories
- Eli Lilly and Company
- Pfizer
- Sanofi
- Purdue University
- Celgene
- University of Pittsburgh (HHSN271200800008-C, U01 MH50467, N01MH 12010)
- McGill University (N01MH12008, HHSN271200800003-C)
- Purdue Pharma
- York University
- National Institutes of Health (n01mh12011-0-0-1, n01mh012009-007, n01mh12008-0-0-1, n01mh12010-0-0-1, n01mh12004-0-0-0, n01mh12007-0-0-0, n01mh012012-001)
- Medical Center, University of Pittsburgh
- University of California, Irvine (HHSN271200800006-C, N01MH 12004)
- National Institute of Mental Health (U01MH50461, N01 MH12007, N01MH-12012, N01 MH012007, U01MH50440, N01MH12008,, U01MH050467, MH-50467, N01 MH012009, U01 MH50477, N01 MH012011, U01MH050447, U01MH050440, N01 MH012012, N01 MH12009, U01MH050453, N01 MH012010, U01MH50467, U01MH050461, N01MH 12004, U01MH50453, N01MH 12010, U01MH050454, N01 MH012004, N01 MH012008)
- National Institute on Drug Abuse (HHSN271200800003C, HHSN271200800006C, N01 DA085550, N01 DA085552, HHSN271200800008C, N01 DA085549, HHSN271200800005C, N01 DA085551, N01 DA085548, HHSN271200800007C, HHSN271200800009C, N01 DA085553, N01 DA085554, R01DA012414, HHSN271200800004C)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, combined type ADHD, long-term outcomes, symptom trajectories, prognostic factors, treatment effects, medication use, adolescent functioning, academic performance, arrests, psychiatric hospitalization
- MeSH terms
- Adolescent, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Behavioral Symptoms, Child, Combined Modality Therapy, Community Mental Health Services, Female, Follow-Up Studies, Humans, Male, Psychiatric Status Rating Scales, Psychotropic Drugs, Reference Values, Regression Analysis, Case-Control Studies, Treatment Outcome, Attention Deficit and Disruptive Behavior Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
